ESSENTIAL FUNCTIONS AND RESPONSIBILITIES:
- Partner with cross functional leads to develop and execute upon program strategy, drive strategic and tactical planning, program budget preparation and management as well as prepare accurate program updates for senior management
- Assist in guiding operational decisions to support requirements for achieving program goals
- Drive planning for key drug development stage-gate decision points (FIH, regulatory filings, study start-up, etc)
- Identify project issues, risks or resource gaps and facilitate resolution
- Ensure relevant communication and alignment across departments, together with internal and external subject matter experts
- Effectively present information, respond to questions, facilitate communications regarding critical issues and impacts related to program strategies
- Establish, maintain and enforce best practices, accurate record keeping and implementation/maintenance of knowledge management databases
- Actively participate in system and process improvements, including documenting policies and procedures to streamline data gathering from all teams and external vendors
- Other duties as assigned or deemed necessary by management
EDUCATION, EXPERIENCE, KNOWLEDGE, SKILLS AND ABILITIES
- Bachelor’s degree in Life Sciences, Biotechnology, Project Management, or a related field. Advanced degree preferred.
- Minimum of 5 years of project management experience in the biotech or pharmaceutical industry.
- Must have sound knowledge of integrated drug development processes from early development to later stage clinical trials. This must include demonstrated experience within regulatory filings and the planning thereof.
- PMP or equivalent project management certification is a plus.
- Strong understanding of biotech industry regulations and standards.
- Excellent leadership, communication, and interpersonal skills.
- Proven ability to manage multiple programs simultaneously.
- Proficiency in project management software and tools.
Similar Jobs
.png)
What We Do
Janux Therapeutics is an innovative biopharmaceutical company developing next-generation therapeutics based on its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to better treat patients suffering from cancer. Janux’s initial focus is on developing a novel class of T cell engagers (TCEs), and its lead product candidates are designed to target clinically validated drug targets. While TCE therapeutics have displayed potent anti-tumor activity in hematological cancers, developing TCEs to treat solid tumors have faced challenges due to the limitations of prior TCE technologies, namely (i) overactivation of the immune system leading to cytokine release syndrome, (ii) on-target, healthy tissue toxicities, and (iii) poor pharmacokinetics leading to short half-life. Janux is using its TRACTr platform technology to engineer product candidates designed to overcome these limitations. Janux is developing a broad pipeline with lead programs targeting prostate-specific membrane antigen (PSMA), epidermal growth factor receptor (EGFR), and trophoblast cell surface antigen 2 (TROP2), with all of its programs currently in the IND-enabling or discovery stage.
